First Amphetamine Transdermal Patch Approved for ADHD. | JAMA;327(17): 1642, 2022 05 03. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

First Amphetamine Transdermal Patch Approved for ADHD.

Larkin, Howard D.

JAMA ; 327(17): 1642, 2022 05 03.

Article in En | MEDLINE | ID: mdl-35503364

Subject(s)

Amphetamine; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Administration, Cutaneous; Amphetamine/administration & dosage; Amphetamine/adverse effects; Attention Deficit Disorder with Hyperactivity/drug therapy; Central Nervous System Stimulants/administration & dosage; Central Nervous System Stimulants/adverse effects; Humans; Transdermal Patch

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Amphetamine / Central Nervous System Stimulants Limits: Humans Language: En Journal: JAMA Year: 2022 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Attention Deficit Disorder with Hyperactivity / Amphetamine / Central Nervous System Stimulants Limits: Humans Language: En Journal: JAMA Year: 2022 Document type: Article